XML Financial LLC Acquires 255 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

XML Financial LLC boosted its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBBFree Report) by 9.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,016 shares of the financial services provider’s stock after acquiring an additional 255 shares during the period. XML Financial LLC’s holdings in iShares Biotechnology ETF were worth $410,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in IBB. Crewe Advisors LLC grew its holdings in iShares Biotechnology ETF by 42.9% during the 4th quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock worth $35,000 after acquiring an additional 78 shares in the last quarter. Northwest Financial Advisors purchased a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at about $42,000. Values First Advisors Inc. purchased a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at about $43,000. Tennessee Valley Asset Management Partners purchased a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at about $44,000. Finally, Massmutual Trust Co. FSB ADV lifted its position in shares of iShares Biotechnology ETF by 164.2% during the fourth quarter. Massmutual Trust Co. FSB ADV now owns 362 shares of the financial services provider’s stock valued at $49,000 after buying an additional 225 shares during the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Price Performance

IBB stock opened at $136.94 on Tuesday. The firm has a 50-day simple moving average of $132.50 and a two-hundred day simple moving average of $133.38. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $141.16.

iShares Biotechnology ETF Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were given a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a dividend yield of 0.37%. The ex-dividend date of this dividend was Thursday, March 21st.

iShares Biotechnology ETF Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Further Reading

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBBFree Report).

Institutional Ownership by Quarter for iShares Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.